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Background: Possible severe bacterial infections, generally defined as sepsis, meningitis, and 
pneumonia, make up for almost a quarter of neonatal mortality. A simplified antibiotic treatment 
(SAT) trial found the SAT to be equally effective for treating infections in infants as an extended 
antibiotic regimen at tertiary facilities. The World Health Organization updated guidelines to 
reflect these findings for infants diagnosed with clinical severe infection, which were then 
implemented in several countries, including Bangladesh. This study investigates the fidelity of 
implementation of the SAT guideline (two injections of gentamycin and seven days of oral 
amoxicillin twice a day) on the safety of the intervention rollout at the family welfare center 
level in two districts in Bangladesh.  
 
Methods: Exploratory factor analysis (EFA) was used to generate four factors of fidelity from 
facility readiness, caregiver adherence, and provider-level adherence measurements and data. 
Four factor scores were produced from the EFA and used as predictors in a multilevel Poisson 
model with robust variance to generate risk ratios to predict risk of treatment failure (persistence 
of infection or death within eight to fifteen days after initiation) from the four factors as well as 
winter season and socioeconomic status quintile.  
 
Results: From the facility readiness, caregiver and provider adherence indicators, four factors 
underlying were identified: oral antibiotic treatment adherence and facility quality, facility 
structural maintenance quality, mobile followup adherence, and secondary injection adherence. 
Of 86 infants diagnosed with clinical severe infection, 11 had treatment failure.  Risk ratios for 
factors oral antibiotic treatment adherence and facility quality, facility structural maintenance 
quality, mobile followup adherence, and secondary injection adherence 1.97 (95% CI: 0.27 – 
14.31), 1.02 (95% CI: 0.22 – 4.81), 0.49 (95% CI: 0.16 – 1.55), and 0.61 (95% CI: 0.11 – 3.43) 
respectively.  An increasing socioeconomic status was protective from treatment failure though 
not significantly, with a RR of 0.60 (95% CI: 0.36 – 1.01).  Lastly, infants that fell ill during the 
winter were 1.63 times more likely to have treatment failure than in other seasons, though not 
significantly (95% CI: 0.39 – 6.84). 
 
Conclusions: This study showed the potential for provider and caregiver adherence to impact 
treatment failure, however a small sample size limits the inferences of the results. Findings may 
be skewed due to only three facilities comprising the majority of treatment failure cases. Facility 
health workers, Government of Bangladesh, and other stakeholders must consider focusing on 
protocol fidelity and other implementation outcomes when scaling up these guidelines to other 
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For infants under two months of age, infections are the greatest cause of mortality globally (1). 
Possible severe bacterial infections (pSBI), generally defined as sepsis, meningitis, pneumonia, 
and tetanus, make up for 24% of neonatal mortality (2).  Sepsis especially, is the third most 
common cause of death for children under five internationally, with most deaths due to sepsis 
occurring in low and middle-income countries (LMIC) (3). Sepsis, a bacterial infection that enters 
the bloodstream and can be caused by a variety of bacterial strains, is a common occurrence in 
LMIC. Even for infants that survive infections, there can be an increased risk for several 
neurodevelopmental and hearing problems (4). The World Health Organization (WHO) has 
recommended a treatment of injectable gentamycin and either penicillin or ampicillin for seven to 
ten days for pSBI at tertiary-level facilities (around 14 to 20 injections total) (5). However, refusal 
for referral for hospitalization in such facilities is quite common in LMIC and low-resource 
settings. Barriers for seeking hospital-level care includes transportation and logistical issues, 
financial constraints and distrust of health facilities due to low quality of care (6–8). Due to the 
high proportion of individuals refusing referral to tertiary-level facilities, community-based 
treatment and management has been proposed in the case of refusal of hospitalization.  
Several large-scale randomized control trials to test the efficacy of a simplified antibiotic regimen 
treatment at the community health facility-level were conducted in the Democratic Republic of the 
Congo, Kenya, Nigeria, Bangladesh, and Pakistan (9).  The simplified antibiotic treatment 
consisted of either two options: injectable gentamycin once per day and oral amoxicillin twice per 
day for seven days (7 injections total) or intramuscular procaine benzylpenicillin and gentamycin 
once per day for two days, then oral amoxicillin twice per day for five days (4 injections total). 




as efficacious as the standard regimen for young infants (0 to 59 days old) (10–12). Following the 
success of these trials, the WHO guidelines on treatment for such infections was updated, and the 
respective governments of the study areas wished to incorporate the new guidelines into protocol 
and scale-up to other health facilities. These guidelines focus particularly on clinical severe 
infection (CSI), a sub-category of PBSI, thus CSI serves as the eligibility criteria for this study. 
The importance of understanding implementation was recognized by key stakeholders of this 
intervention, thus a study researching different facets of implementation was conducted in 
concurrence with the rollout of the simplified antibiotic regimen in all the study countries, 
including Bangladesh.  
Bangladesh, a nation with remarkable progress in health development, is working towards 
achieving the Sustainable Development Goal of an neonatal mortality ratio (NMR) of 12 deaths 
per 1000 live births, with a current NMR of 23 per 1000 live births (13). Given the high attribution 
of neonatal infection to mortality, pSBI is an area of focus that can potentially lead to great 
reductions in neonatal mortality. In this paper, the process and efforts of the scale-up as conducted 
by the Government of Bangladesh will be investigated, specifically understanding factors of 
implementation and how they impact the health outcomes of the intervention in the context of the 
current health system of the nation.  
In the field of public health, it is often observed that interventions that are efficacious in controlled 
settings are not as effective in real-world settings. Thus, there is a disconnect in understanding the 
process of implementation, diffusion, and translation of efficacious programs into feasible and 
sustainable effective programs. The diffusion of innovation theory by Rogers in 1995 was an initial 
model that conceptualized an understanding of how research can be put into practice and adopted 




often cited as implementation science, which is a developing area of research for those interested 
in program and intervention evaluation of impact and outcomes. Implementation science is “the 
scientific inquiry into questions concerning implementation- the act of carrying an intention into 
effect, which in health research can be policies, programs, or individual practices (collectively 
called interventions)” as defined by Peters and colleagues (15). Understanding and analyzing 
implementation of interventions can benefit both program implementers and researchers in 
elucidating why certain efficacious interventions are not effective in real world settings and 
ultimately aid in adapting programs to increase overall effectiveness.  
As with all newly developing fields, the field of implementation science still has inconsistency in 
the terminology used for defining variables of interest. However, several general (i.e. non-
standardized) implementation outcomes have been established in the literature. Implementation 
outcomes are “the effects of deliberate and purposive actions to implement new treatments, 
practices, and services”, as defined as Proctor et al. (16). For a concept to be considered a type of 
implementation outcome, it must precede the service or clinical outcome of the intervention but 
succeed implementation strategies, and are indicators of implementation success (17). The most 
common and standard implementation outcomes are: appropriateness, acceptability, feasibility, 
adoption/uptake, fidelity, penetration, cost-effectiveness, and sustainability (15–19).  
In this study, the impact of fidelity by the health facility workers and caregivers, as well as facility 
readiness will be analyzed in relation to the service outcome safety (Figure 1). Fidelity is the degree 
to which an intervention was implemented as designed in the original protocol, policy, or plan 
(15,16). Fidelity, a multi-domain construct, can contain from two to five domains depending on 
differing definitions of fidelity. For the purpose of this study, fidelity will contain three main 




Adherence is the extent to which an intervention is being delivered as design or written. Dosage is 
the frequency and duration of the intervention that is received as intended by the designers of the 
intervention. Lastly, quality of delivery is the manner in which an intervention worker delivers the 
intervention compared to some type of standard or expectation (16,19–24). More commonly, either 
a representative or comprehensive method of measurement is used to conceptualize fidelity. The 
representative approach measures fidelity using estimates from a single domain as a representation 
of all domains involved, while the comprehensive method uses an aggregate measure across 
multiple domains (23). These forms of measurement are unable to distinguish and incorporate the 
heterogeneity within multiple domains as well as recognizing correlations and interactions 
between domains. A more complex method, namely using factor analysis, will be utilized to 
capture these three domains and the interactions and influences on each other in this study.  
Fidelity of interventions is a highly important area of interest for intervention implementers and 
researchers for multiple reasons. Program failure in terms of unachieved clinical outcomes is often 
attributed to conceptual flaws of the intervention rather than the implementation; thus study of 
fidelity helps to understand accurate interpretation of intervention or treatment effects (25). 
Assessing fidelity also allows for identification of how differing fidelity levels of program 
components can impact both mediating variables and final clinical outcomes through effect 
modification. Fidelity also informs other implementation outcomes such as feasibility, adoption, 
and acceptability. An intervention with low fidelity may be due to a lack of acceptability or 
feasibility, thus this information can be used to reform future implementation efforts (21).  
The degree to which caretakers of infant patients adhered to intervention guidelines as 




considered as a key aspect of adherence. It is hypothesized that as the infant caregiver adherence 
of the treatment in its full form increases, safety of the treatment will also increase.  
The final outcome of interest in this study is the safety of the intervention. Safety, a service 
outcome as defined by the IOM Standards of Care, is “freedom from accidental or preventable 
injuries produced by medical care” (13). Safety is an essential area of focus for intervention 
studies, as it is an ultimate necessity for all programs and interventions to not unintentionally harm 
the public. To assess the feasibility of and evidence for scaling up the simplified antibiotic 
treatment to other districts in Bangladesh, the safety of the intervention must be investigated. For 
the purpose of this study, safety will be defined as the lack of self-reported treatment failure 
following the initiation of the simplified antibiotic treatment.  
This study seeks to answer the following question: how do varying levels of fidelity of the 
implementation process impact the degree of safety of a simplified antibiotic regimen intervention 
for infants with clinical severe infections that are treated at a lower-level facility due to refusal of 
referral in Bangladesh? It is hypothesized that the lower provider and caregiver adherence and 







Study Background and Design  
The implementation research study on the rollout of the revised antibiotic regimen WHO 
guideline, as conducted by the Bangladesh Ministry of Health & Family Welfare (MOHFW), 
began in the first year of the scale-up from September 2015 to August 2016. Using a mixed 
method approach, Johns Hopkins University (JHU) evaluated the implementation of the rollout 
in several first-level facilities two districts: Sylhet (n=9) and Lakshmipur (n=10).  Bangladesh is 
divided into 8 administrative divisions; Sylhet district is located in the Sylhet division of 
Bangladesh, while Lakshmipur is located in the Chittagong division. Historically, both divisions 
have had poor maternal and newborn health trends as well as low health facility utilization in 
comparison to other divisions (26). The first-level facilities where the rollout took place are 
called union health and family welfare centers (UHFWC), which provides outpatient services 
and is staffed by two or three health workers.  
There are three types of health workers in this study. The first is the Sub-Assistant Community 
Medical Officer (SACMO), has been trained for three years on primary care as well as child 
health, and conducts the main assessment on incoming infants and provides the appropriate 
treatment based on international Integrated Management of Child Illness (IMCI) guidelines at the 
UHFWC. The next type of health worker is the Family Welfare Visitor (FWV), who has been 
trained for eighteen months on maternal and child health care; they provide the second-day 
injections for CSI if the SACMO is not present. Lastly, there is a Family Planning Inspector 
(FPI), who is a manager that supervises community health workers. The FPI conducts the follow-




The protocol for a sick infant is as follows: if a caretaker brings an infant to the UHFWC who 
appears to have symptoms of clinical severe infection then the SACMO will first administer 1 
dose of injectable gentamycin and oral amoxicillin. The SACMO will refer the infant to the 
nearest Upazila Health Complex for management, however in the case of referral non-
compliance, the updated WHO guidelines will be used. The infant should return to the UHFWC 
on the second day for the 2nd dose of injectable gentamycin, while receiving oral amoxicillin 
twice daily for 7 days. From the third day onward, the oral amoxicillin should be administered at 
the home. Additionally, on the 4th and 8th day of treatment, follow-up should be conducted by a 
health worker by phone in order to assess the condition of the infant. If the infant condition is not 
improving, the family must notify the SACMO and reach the referral facility.  
There are three surveys that this study will utilize to estimate the impact of fidelity on adoption 
and safety of the antibiotic treatment. The first survey is a facility-level assessment; in August of 
2015, a facility readiness assessment was carried out on 9 first-level facilities in Sylhet and 10 in 
Lakshmipur for facilities that had a SACMO posted at the time of the assessment.  This survey 
assessed the availability of drugs, equipment, and other indicators of a fully-functioning health 
facility. The variable measurements of this survey will be discussed in further detail in a later 
section.  The second survey used is a household survey that was conducted for all married 
women of reproductive age (WRA) in the selected study facility area if the woman had a live 
birth within the last two months starting in July of 2015. Community Health Workers (CHWs) 
screened 97,736 women from November 2015 to August 2016, with 4,081 eligible women 
(n=1,832 in Sylhet, n=2,249 in Lakshmipur) identified for survey. Lastly, a community case 
follow-up surveyed caregiver of the young infant patients that had been classified as having a 




follow-up was conducted by the government health workers on day 8 of the treatment, while the 
study team followed up between day 9 to 15.  
Eligibility Criteria 
This study investigates aspects of the adherence, dosage, and quality of delivery for infants that 
received a simplified antibiotic treatment for CSI. Thus, to be eligible for this analysis, infants 
must have been diagnosed with CSI, which reduced the sample size (n=86). Due to discrepancies 
in data, only information from the case-followup dataset was used for adherence measures. 
Measurement of Domains 
In this study, fidelity is a construct composed of two domains: adherence to original intervention 
protocol and quality of delivery. Provider and caregiver adherence of intervention protocol and 
quality of delivery were measured with the variables as described in the table below. As 
previously discussed, fidelity of an implementation is a construct that contains the domains of 
adherence, exposure, and quality of delivery as per the Proctor definition (16). In this study, data 
on exposure of the intervention, which can be construed as the dosage of antibiotic received, was 
difficult to verify due to conflicting and missing information from the provider and the caregiver 
on the exact dosage administered to the infant. Therefore, fidelity is measured through only 
adherence and quality of delivery of the intervention. Additionally, quality of delivery 
information was limited and available in only qualitative interview settings, thus facility 
readiness was used as a proxy measure of the quality of delivery. The outcome of this study, 
safety, was reported by the caregiver the persistence of infection or death within eight to fifteen 
days after antibiotic initiation when the household survey was conducted.  
Model specifications  




 (unobserved) variables of caregiver adherence, fidelity, provider adherence, and facility 
readiness in relation to the safety of the simplified antibiotic treatment. Initially an exploratory  
 
Table 1. Domains and Variable Descriptions 
 
factor analysis (EFA) was used to determine which indicators would provide the greatest fit for 
the confirmatory factor analysis (CFA). The CFA then tests if the prespecified conceptual model 
Domain  Variable 
Adherence 
(Provider, as reported by Caregiver) 
Gentamycin injection administered on Day 1 
Provider informs caregiver to return for second injection on Day 
2 
Provider gives caregiver amoxicillin oral medication to 
administer at home 
Provider informs mother the correct frequency with which to 
administer oral amoxicillin at home 
Gentamycin injection administered on Day 2 
Notified caregivers to return to clinic if infection persisted 
Notified caregiver of mobile followup on Day 4 
Followed up with caregiver via mobile on Day 4 or 5 
Followed up with caregiver in person on Day 8 or 9 
Adherence 
(Caregiver, Self-reported) 
Returned to UHC on Day 2 after being told to return by provider 
Caregiver knowledge of oral antibiotic details 
Caregiver recall of oral antibiotic administration frequency 
Caregiver remembers to administer oral antibiotic 
Caregiver knowledge of infection persistence danger signs 
Quality of Delivery 
(Facility Readiness Assessment) 
Provision for handwashing at UHC 
Constant electricity availability without outages at facility 
Information Boards with UHC times available 
Advice box available for clinic suggestions and improvement 
comments 
Drinking water available 
Essential drug availability (injectable gentamycin, syrup and 
pediatric drop amoxicillin) 
Essential equipment availability (measuring tape and board, 
weighing machines, stethoscopes, thermometers, ARI timer, 
clock/watch, safety box, pulse oximeter, oxygen concentrator) 
Supply and logistics availability (patient registers, referral slip, 
job aids) 
Received supervisory visit within the last three or one month 
Treatment failure (Outcome) 





fits the data adequately; if that is the case, then generalized structural equation can be used to 
estimate the impact of fidelity and caregiver adherence on intervention safety. The software  
MPlus Version 7.4 was used for the EFA and CFA analyses (28) and Stata Version 14 was used 
for the factor score prediction and multilevel Poisson regression (29). As depicted in Figure 1, 
fidelity would be used to predict the safety of the simplified antibiotic treatment, adjusting for 




Figure 1. Conceptual Framework of Implementation Fidelity Construct and Safety   
Fidelity: Degree to which an intervention was implemented as prescribed by 
the original protocol 




Domain 1- Provider 
Adherence: the 
intervention is being 
delivered by health 






Domain 2- Facility 
Readiness:  quality of 
the facility as 
determined by a facility 
readiness assessment  
 
Safety: Degree to which treatment 
failure during implementation of 





Socioeconomic Status of Caregiver/ Household 
 
 
Domain 3- Infant 
Caregiver Adherence: 
Degree to which 
caregivers adhered to 
intervention guidelines 
as recommended by 
health care worker  
 




However, several assumptions must be met before the initial confirmatory analysis can be 
considered valid. If multiple tests of fit do not deem the a priori model as fitting the observed 
data, then a generalized structural equation model cannot be used to further predict the safety of 
the intervention as several assumptions will be violated. These assumptions include the 
specifying the model constraints and identification. The variance of latent variables must be 
fixed to one, pass the “two-indicator rule” which requires at least two factors, at least two 
indicators per factor, each indicator only points to one latent variable, non-correlated errors, and 
factors are correlated. Additionally, the “t-rule” must be hold, which indicates that the number of 
equations of the model (n(n+1)/2=10)) must be greater than the number of unknown parameters. 
Lastly, the two-step rule must be met, which requires assessing identifiability of the confirmatory 
factor analysis model, then assessing the identifiability of the entire model, not only the latent 
variable component of it (30) . Rotations of the EFA and CFA will be varimax, which assumes 
no correlation between factors of the model after finding no substantial correlation between 
factors. Parameters of the model are estimated by choosing estimates through a fitting function 
of maximum likelihoods. The number of factors chosen is determined through a parallel analysis, 
which uses a bootstrap method to compare observed eigenvalues of factors to factor eigenvalues 
that would be generate by random chance (see Figure 2). The model will then be evaluated using 
global tests of goodness of fit: Root Mean Square Error of Approximation (RMSEA), Wald test, 
Comparative Fit Index (CFI), and the Tucker-Lewis Index (TLI). If the CFA test statistics 
indicate that the a priori model is not a good fit for GSEM, then factors will not be used as one 
underlying “fidelity”, but rather will consist of factors for adherence and facility readiness as 





Figure 2. Example of a path diagram of a confirmatory factor analysis model  
This is an example of a CFA model with two factors and three measured indicators for each 
factor (31). The following is the overall CFA model equation: 𝑋 = 𝛬𝜉 + 𝛿 
where X is the vector of observed/measured variables, Λ is the matrix of factor loadings, ξ is the 
latent variable (factor), and 𝛿 is the vector of unique errors. 
Thus, the equation for this specific CFA model would be the following: 
 
These factors will then be used in a Poisson regression with robust variance, adjusting for group 




predict the relationship between the adherence and facility readiness factors with the safety of the 
intervention. Socioeconomic status quintile was generated using PCA of maternal education 
level, maternal occupation, household remittance status, number of household members, and 
categories of number of working household members.  The use of a Poisson regression with 
robust variance allows Risk Ratios (RR) to be generated, which are more easily interpretable 







Of the 86 infants diagnosed with CSI that initiated the simplified antibiotic treatment, only 11 
had reported treatment failure (12.7%). 8 of the 11 events were reported from the same three 
facilities, thus statistics comparing characteristics of facilities with verse without treatment 
failure events are inflated. As depicted in Table 2, there were no significance difference of the 
provider-level adherence, caregiver adherence, and household SES when comparing those 
reporting treatment failure outcomes with those who did not, except for facility-level variables of 
handwashing provisions, essential equipment availability, and essential supply and logistic 
material availability. The majority of treatment failure events occurred during the winter season. 
After running an initial principle components analysis (PCA) with all provider-level adherence, 
caregiver adherence, and facility readiness variables, a parallel analysis justified the retention of 
four factors during the EFA (see Figure 3).  
Exploratory Factor Analysis – Factor Fit and Representations 
The fit statistics for the EFA demonstrated a reasonable fit, with only 1 out of 4 of the statistics 
not demonstrating an adequate fit of the data into the factors (see Table 3). The RMSEA statistic 
was 0.106, CFI was 0.956, TLI was 0.876, and Wald Test had p value less than 0.05. This 
warranted moving onto a CFA, where the apriori model roughly based on the factors suggested 
in the previous EFA could be tested to see the adequacy of the fit given the correlation structure 
of the data.  
The EFA loading estimates can be interpreted as correlation coefficients between the variable 
and the factor, thus high loadings cluster together to form a factor. Uniqueness indicates the 




communality), thus low uniqueness indicates that factors will extract most of the variance from 
the variable measurements. The EFA factor loadings suggested four relatively coherent factors.  
 
Table 2: Characteristics of facilities and households  

























Overall Provider Adherence Score  
(median, IQR) 2 (1.33, 2) 2 (1.33, 2) 0.60 
Frequency of Power Outages   
0.45 
Often 30 (40%) 6 (55%) 
Sometimes 11 (15%) 0 (0%) 
Rarely 34 (45%) 5 (45%) 
Handwashing Provisions   
0.047 
None 1 (1%) 1 (9%) 
One 31 (41%) 1 (9%) 
Two 43 (57%) 9 (82%) 
Drinking Water Provision 64 (85%) 7 (64%) 0.095 
Adequate drug supply score  
(median, IQR) 1.78 (1.56, 1.78) 1.56 (1.44, 1.78) 0.016 
Essential Equipment Availability Score 
(median, IQR) 1.67 (1.67, 1.67) 1.67 (1.44, 1.67) 0.03 
Essential Supply and Logistic Material 
Availability (median, IQR) 1.44 (1.39, 1.44) 1.39 (1.39, 1.44) 0.008 
Supervisory Visit Frequency   
0.49 
None within last 3 mo. 26 (35%) 2 (18%) 
Within last 3 mo. 35 (47%) 6 (55%) 












Overall Caregiver Adherence Score 
(median, IQR)  
2.33 (1.67, 2.33) 2.00 (1.67, 2.33) 0.25 
Socioeconomic Status Tertile   
0.78 
Low 24 (32%) 5 (45%) 
Middle  26 (35%) 3 (27%) 










Winter 26 (35%) 6 (55%) 
0.65 
Spring 16 (21%) 3 (27%) 
Summer 12 (16%) 1 (9%) 
Rainy Season 19 (25%) 1 (9%) 
Late Autumn 2 (3%) 0 (0%) 
 
Figure 3. Parallel Analysis to Plot Factor Eigenvalues  
 
Table 3: Test fit statistics from EFA  
Model Fit Test Estimate  Indicates adequate fit? 
Root Mean Square Error of Approximation 0.106 Yes 
Comparative Fit Index 0.956 Yes 
The Tucker-Lewis Index 0.879 No 
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In the first factors the following variables following were highly loaded:  provider-level 
adherence of oral antibiotic administration duration instructions, provider-level adherence of oral 
antibiotic administration frequency instructions, caregiver knowledge of oral antibiotic details, 
caregiver recall of oral antibiotic administration frequency, facility handwashing provisions, and 
facility supervision frequency.   
This factor thus represents “Oral Treatment Adherence and Facility Quality”. The next factor had 
the high loading variables of provider-level adherence of infection persistence instruction, 
constant electricity availability without outages at facility, facility supplies and logistics material 
availability, and facility supervisory visits in the last 1 and 3 months. Thus, this factor represents 
“Facility Structural Maintenance Quality”. Factor 3 loaded well with the provider-adherence to 
informing caregivers of the planned mobile followup on Day 4 of the treatment and the provider-
adherence of actually conducting the mobile followup on Day 4. This factor represents “Mobile 
Followup Adherence”.  The last factor was loaded with the caregiver adherence of returning to 
the facility for the second injection of Gentamycin, thus this factor is called “Day 2 Injection 
Adherence”.  
 
Confirmatory Factor Analysis Results  
Using the CFA model as seen in Figure 3, the model first had to undergo model identification to 
determine if there are enough known parameters to solve for equations of unknown parameters 
during CFA. The two-indicator rule, T-rule, and fixed variance rules were met.  
After implementing the CFA, the fit statistics indicated a poor fit for GSEM, therefore the 
GSEM model was not conducted as originally anticipated (see Table 6). Estimates from the 




fit, the multilevel (clustered at the facility level) Poisson regression with robust variance model 
was used to predict the relationship with the factors developed from the EFA and the outcome of 


























Day 1 provider gives instruction 
for oral antibiotic administration 
duration 
0.93 -0.11 0.23 0.16 0.04 
Day 1 provider gives instruction 
for oral antibiotic administration 
frequency 
0.54 0.11 0.72 0.10 0.17 
Day 1 or 2 provider tells caregiver 
to return if no improvement in 4 
days 
0.32 0.73 0.08 -0.09 0.35 
Day 1 provider informs mother of 
mobile followup on Day 4 
0.02 0.35 0.75 0.00 0.32 
Day 4 provider followup on 
mobile  
-0.01 -0.01 0.96 0.12 0.07 
Constant electricity availability 
without outages at facility 
-0.28 0.59 0.09 0.53 0.28 
Provision for handwashing at 
facility 
0.52 -0.42 -0.31 -0.50 0.22 
Essential equipment availability  -0.05 0.96 0.06 0.04 0.07 
Supplies and logistics material 
availability  
-0.03 0.71 0.16 0.02 0.47 
Supervisory visits in the last 1 and 
3 months 
0.57 0.36 -0.34 -0.31 0.33 
Caregiver returned to facility on 
Day 2 for injection  
0.32 -0.04 0.15 0.88 0.10 
Caregiver knowledge of oral 
antibiotic details 
0.63 -0.08 0.22 -0.48 0.32 
Caregiver recall of oral antibiotic 
administration frequency 




Table 5. CFA Model Identifiability  
Model Identifiability Rule Model Passes Test? 
Two-Indicator Rule (CFA) Yes 
Variance of Factors Fixed  Yes 
T-rule Yes 
Two-Step Rule (CFA and GSEM)  No 
 
 
Table 6: CFA test statistics  
Model Fit Test Estimate  Indicates adequate fit? 
Root Mean Square Error of Approximation 0.115 No 
Comparative Fit Index 0.764 No 
The Tucker-Lewis Index 0.698 No 
Wald Test P < 0.05 Yes 
 
 
Table 7: Final Multilevel Poisson Regression Model  
n of CSI Infants=87; n of Facilities=11; 
n of  
Risk Ratio P-Value 95% CI 
Factor 1: Oral Treatment Adherence and  
Facility Quality 
1.97 0.50 0.27 – 14.31 
Factor 2: Facility Structural Maintenance Quality 1.02 0.98 0.22 – 4.81 
Factor 3: Mobile Followup Adherence 0.49 0.22 0.16 – 1.55 
Factor 4: Secondary injection adherence 0.61 0.58 0.11 – 3.43 
Socioeconomic Status Tertile  0.60 0.06 0.36 – 1.01 
Winter Season 1.63 0.51 0.39 – 6.84 




Figure 3: Confirmatory Factor Analysis Model Variable Specification (Factor Abbreviations: D2A- Day 2 Adherence; MFA- Mobile Followup 




The model results produced risk ratios for factors oral antibiotic treatment adherence and facility 
quality, facility structural maintenance quality, mobile followup adherence, and secondary 
injection adherence 1.97 (95% CI: 0.27 – 14.31), 1.02 (95% CI: 0.22 – 4.81), 0.49 (95% CI: 0.16 
– 1.55), and 0.61 (95% CI: 0.11 – 3.43) respectively.  An increasing socioeconomic status was 
protective from treatment failure though not significantly, with a RR of 0.60 (95% CI: 0.36 – 
1.01).  Lastly, infants that fell ill during the winter were 1.63 times more likely to have treatment 







The results of this study indicate that certain aspects of provider and caregiver adherence as well 
as facility structural maintenance quality are shown to be linked with a decrease in treatment 
failure, though not significantly. However, the factor of oral treatment adherence and facility 
quality appeared to be linked with increased risk of treatment failure, though not significantly. 
Every increasing tertile of SES was insignificantly associated with a 40% decrease in risk of a 
treatment failure. Additionally, the winter season was associated with a higher risk of treatment 
failure compared to other seasons, though not significantly.  
Some of these findings were unexpected, especially the relationship between oral treatment 
adherence/facility quality with an increased risk of treatment failure events. However, other 
findings reinforce previous general knowledge of the positive impacts of implementation 
adherence and facility quality on patient-level outcomes and intervention success (32,33). These 
results demonstrate that incorporating implementation outcomes such as fidelity can substantially 
explain the outcomes of interventions, which if adequately conducted, fills in the “black box” of 
implementation process and activities which occurs in between key efficacy findings and final 
program evaluation.  
Given the highly context-dependent nature of implementation research, there have been no other 
known studies that have investigated the impact of implementation fidelity on a simplified 
antibiotic regimen for infants in real-world settings. However low adherence of the simplified 
antibiotic regimen for infants with clinical severe infection in controlled settings of effectiveness 
studies have shown a higher likelihood of treatment failure  (11,12,34). Past studies of antibiotic 
regimens for treating non clinical severe infections have also seen a lower treatment 
effectiveness with lower caregiver and provider adherence (35–37). These results demonstrate 




structural maintenance. There should be special attention paid to the impact of mobile followup 
adherence as well as adherence to administration of the second injection. Infants who received 
the second injection were more likely to have a positive outcome, as well as those who received 
the mobile followup from the provider to check on the condition of the infant and provide advice 
if needed. Therefore, the importance of these components can be more enforced during trainings 
and supervision, as well supported through higher administration as being high priorities actions 
of the protocol. Thus implementing partners, national governments, and any potential 
stakeholders should emphasize the role of intervention fidelity as well as facility readiness and 
maintenance when scaling up simplified antibiotic therapy for infants in rural areas. Future 
investigators who are studying the rollout and scaleup of the simplified antibiotic treatment for 
infants should also take heed to measurements of fidelity and other implementation outcomes 
that can highly impact the effectiveness of the guidelines.  
 
Limitations 
There are several limitations to this study. Firstly, the sample size of infants with clinical severe 
infection who were followed up after the treatment was limited to 86 infants. Of those 86, only11 
were reported to have treatment failure when surveyed. This makes the Poisson model estimates 
unstable, especially as the majority of infants were from the same three facility and time period 
during the winter season, thus facility level adherence estimates were highly skewed to that of 
those three facility areas where most of the treatment failure occurred. The limited sample size 
could have also affected the fit statistics which did not allow for proceeding with a generalized 
structural equation model. A lack of variance in the outcome can highly impact the stability of 




regression model. Additionally, given the structure of the questions asked of facilities and 
caregivers, validated scales or questionnaires that can specify and differentiate aspects of 
underlying facility readiness and quality of delivery to ensure adequate amount of variation in 
the responses will produce more reliable and valid factors. Validated scales that have high 
translation and criterion-related validity can be used to create more robust measurements of 
facility readiness as well as aspects of facility and caregiver adherence (35,38–41). 
Measurements of exact antibiotic dosage were also not included in this analysis due to missing 
information, however this could also greatly impact treatment failure outcomes and is a 
component of the underlying construct of fidelity as presented by Proctor and colleagues (16). 
Quality of delivery was also not measured directly, thus facility readiness near the end (August 
2016) of the intervention was used as a proxy for this domain. However, it is possible that a 
facility with high readiness and/or adherence had a low quality of delivery, which would not 
have been apparent when using facility readiness measured instead of quality of delivery. The 
facility readiness could have also deteriorated by August 2016 during the intervention 
implementation, thus the facility readiness indicators may not have been truly representative of 
the facility quality at the time of the antibiotic treatment. This could possibly have biased the 
estimates of the model, and be related to why there was an increase of treatment failure outcome 
risk with increases of facility quality and components of provider protocol adherence. The 
outcome of treatment failure events may also be biased, as the duration of infection progression 
may have greatly varied from infant to infant, however it is difficult to accurately collect this 
data at the union facility level. Infants with reported treatment failure events may have had the 
infection for a longer duration than those without. Further information on when treatment was 




Additionally, provider and caregiver adherence was self-reported by the caregiver rather than a 
neutral and independent source. Data provided by the caregiver is subject to recall bias, where 
caregivers may have reported the provider adherence inaccurately due to not remembering subtle 
yet significant aspects of protocol adherence, for example remembering if the provider 
mentioned that s/he will conduct a followup through mobile phone after two or three days. They 
may have also overreported adherence behaviors.  Skip patterns of the data also incorporated 
another element of complexity in the analysis, so some adherence measures were combined into 
categories that had options for not being able to complete the action due to not having completed 
a necessary previous step. Though polychoric correlation structures were used for the EFA and 
CFA, the categories were not perfectly ordinal thus interpretation of the EFA factor loadings 
may not be as intuitive as continuous variables. Lastly, there can be residual confounding that 
occurred due to lack of data on other potential confounders such as natural disasters that could 
have affected both fidelity of the intervention and the occurrence of treatment failure outcomes.  
 
Recommendations  
For future implementation research studies, validated scales to measure quality of delivery, 
facility readiness, and provider adherence could provide a more nuanced picture of the true 
impact of intervention fidelity on the intervention success. A larger sample size can also allow 
more causal inference of various implementation outcomes on the success of the policy changes. 
Differing implementation strategies that are catered to a facility’s needs can also be investigated 
to view the impact of varying strategies on implementation barriers that arise throughout the 
scaleup of the guidelines. Qualitative analysis also provides valuable and complementary data to 




implementation process and testify to the acceptance, feasibility, fidelity, and effectiveness of the 
intervention. Future publications that analyze implementation using mixed methods will 
contribute further to the understanding of caregiver and provider adherence, facility readiness, 
and quality of delivery on intervention success (42).  Given the importance of contextual factors 
for incorporating into implementation research, future studies should highly involve the local 
implementers and health care providers in the design and research process to better capture 









This study investigated the relationship between implementation outcome of fidelity with the 
safety of a rollout of simplified antibiotic treatment for infants with clinical severe infection at 
union-level facilities in two districts of Bangladesh. Using an exploratory factor analysis, four 
factors related to provider and caregiver protocol adherence, and facility readiness were 
generated as predictors of treatment failure outcomes post-treatment as reported by the caregiver. 
A multi-level Poisson model with robust variance was used to generate risk ratios to predict the 
risk of treatment failure. It was found that adherence related to the second gentamycin injection 
administration and the provider following up with the caregiver on the condition of the infant 
through a phone call on the fourth day since the initial injection was highly protective from the 
infant facing any treatment failure, though not significantly. However higher oral antibiotic 
administration adherence of both provider and caregiver had a higher risk of treatment failure, as 
well as higher facility structural maintenance quality, though neither significantly. Higher 
socioeconomic status was also related to positive outcomes following treatment, while winter 
season was related to a higher risk of treatment failure, again not significantly. These results 
demonstrate the potential impact of certain components of provider and caregiver protocol 
adherence on intervention success, however a limited sample size restricts the level of causal 
inference these results can provide. Future studies on the implementation strength of the 
simplified antibiotic treatment for infants with CSI and even PSBI should incorporate elements 
of fidelity measurements and other implementation outcomes into the study design for a more 
robust and comprehensive understanding of the implementation process and the relationship with 
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